Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients

This study examines the role of M2BPGi, a novel seromarker for chronic hepatitis, in predicting hepatocellular carcinoma (HCC) among untreated chronic hepatitis B (CHB) patients. In this nested case-control study, 1070 samples were assayed for M2BPGi, including 357 samples from HCC cases, and 713 sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jessica, Hu, Hui-Han, Lee, Mei-Hsuan, Korenaga, Masaaki, Jen, Chin-Lan, Batrla-Utermann, Richard, Lu, Sheng-Nan, Wang, Li-Yu, Mizokami, Masashi, Chen, Chien-Jen, Yang, Hwai-I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662597/
https://www.ncbi.nlm.nih.gov/pubmed/29085039
http://dx.doi.org/10.1038/s41598-017-14747-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662597/
https://www.ncbi.nlm.nih.gov/pubmed/29085039
http://dx.doi.org/10.1038/s41598-017-14747-5

Ejemplares similares